Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update): Draft scope

You can now comment on this draft scope. The scope defines what the guideline will (and will not) cover.

The consultation closes on 14/04/2022 at 5pm

How to comment

1. Register your organisation

Your organisation needs to be registered as a stakeholder before we can accept comments.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

• Draft scope

Background documents

• Equality impact assessment
• Developing NICE guidelines: how to get involved

3. Make your comments

• You must use the comments form
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another registered organisation, send a joint response.

4. Email the form to us 

Email: diabetescyp@nice.org.uk

Deadline:14/04/2022, 5pm